{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By ROBERT CYRAN", "person": [{"firstname": "Robert", "rank": 1, "lastname": "CYRAN", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "384", "keywords": [{"rank": "1", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Abbott Laboratories", "is_major": "N", "name": "organizations"}, {"rank": "3", "value": "Johnson & Johnson", "is_major": "N", "name": "organizations"}, {"rank": "4", "value": "St Jude Medical Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "Wrapping up deals with Alere and St. Jude has troubled Abbott Laboratories; a cash infusion will come at a welcome time.", "pub_date": "2016-09-20T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "Wrapping up deals with Alere and St. Jude has troubled Abbott Laboratories; a cash infusion will come at a welcome time....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/09/20/business/dealbook/abbotts-sale-of-eye-surgery-unit-should-ease-its-merger-woes.html", "slideshow_credits": null, "blog": [], "_id": "57e020bc95d0e021d79871de", "headline": {"main": "Abbott\u2019s Sale of Eye Surgery Unit Should Ease Its Merger Woes", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}}